Business
Australia strikes deal for new Covid pill that could be used in treatment by early 2022 – The Guardian Australia
Molnupiravir has been shown to prevent serious illness and death, although it is still in late stage clinical trials
Australia has secured 300,000 courses of molnupiravir, an antiviral capsule to treat Covid-19 that could be in use by early 2022.
The Morrison government has struck a supply agreement with MSD to provide the oral treatment if it is approved by the Therapeutic…
Continue Reading
-
General22 hours agoDarwin hosts its first Asian Cup qualifier match, deepening cultural ties between nations
-
Business13 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares
-
General22 hours agoKatie Boulter says death threats and abuse highlight dark side of tennis betting
-
Noosa News22 hours agoThieves ram car into Bribie Island shopping centre to rob jewellery store